Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy.
- Resource Type
- Article
- Source
- ACS Applied Materials & Interfaces; 4/3/2019, Vol. 11 Issue 13, p12342-12356, 15p
- Subject
- Language
- ISSN
- 19448244